Search

ALL PSYCHEDELIC AND PSYCHEDELIC STOCK NEWS

Psyched Wellness ‘Calm’ Now Available at Locations in the United States.

PSYCH STOCK NEWS Editor | Curator -
Psyched Wellness Lists Calm at All Erewhon Market Locations in the United States Toronto, Ontario--(Newsfile Corp. - September 7,...
View Post

Stressed Wall Street Execs Flock to Ketamine Therapy Sessions (NY Post)

CLINICS Editor | Curator -
Therapy’s a trip for these Wall Street executives. Wealthy stock traders are flocking to a Manhattan-based ketamine therapy practice that doles out...
View Post

Amanita Muscaria in a Vape!

Featured Editor | Curator -
Vaping amanita mushrooms? You heard it right! The new Happy Daze Amanita Muscaria...
View Post

Interview: Dr. Deborah Nash, Ibogaine and Miami Based DemeRX.

INTERVIEW Editor | Curator -
Partnered with ATAI Life Sciences ATAI. Amazing Interview. "I said there's no way that you can take one dose of Ibogaine...
View Post

Psychedelic Marketing Tips: Adrian Morrison

INTERVIEW Editor | Curator -
The Absolute Champion of Internet Advertising, Adrian Morrison, makes a believer out of Jordan, which is saying everything! Why can’t this be...
View Post

Shark Tank’s Kevin Harrington Invests In Psychedelics Company Psycheceutical (BWVI). Forbes

2023 Watch List Editor | Curator -
Mike Zapolin, Kevein Harrington and CEO Chad Harman Another Shark Tank original has invested in the psychedelic industry.
View Post

Adding Psycheceutical Bioscience (BWVI) $0.14 to Watch List. (Ketamine.)

2023 Watch List Editor | Curator -
Above: Lamar Odom and Psychedelic Advocate Mike Zappy Zapolin. We’re Calling a Sector Bottom, and Psycheceutical (BWVI)...
View Post

Ketamine and Yale University

INTERVIEW Editor | Curator -
Depression is one of the most common and most debilitating mental health disorders, affecting some 17 million adults in the US. It...
View Post

Johns Hopkins Receives $20M From Roland R. Griffiths Ph.D. Professorship Fund For Psychedelic Research

CLINICAL TRIALS Editor | Curator -
John Hopkins Center for Psychedelic and Consciousness Research Johns Hopkins University academics just a got a boost in their funding thanks to...
View Post

Is ATAI Live Sciences (ATAI) $2.00, Finally Turning?

2023 Watch List Editor | Curator -
After Dropping 94% From Post IPO high from $19.45, a loss of exceeding $3 billion and change, ATAI is in the early...
View Post

PSYCHECEUTICAL TO CONDUCT THE FIRST EVER PHASE I AND II CLINICAL TRIALS OF A NOVEL KETAMINE TOPICAL CREAM TO TREAT PTSD

INTERVIEW Editor | Curator -
Psycheceutical ​​enters into agreement with iNGENū to conduct ​human ​clinical trials of NeuroDirect™ ketamine topical ​in Australia
View Post

The Kahner Global Cannabis & Psychedelics Investment Summit.

PSYCH NEWS Editor | Curator -
Kahner Global’s 8th annual Cannabis & Psychedelics Investment Summit  When:...
View Post

Awakn Life Sciences (AWKNF) $0.30 Announces Signing of Lease for Second Clinic in Norway.

CLINICS Editor | Curator -
Trondheim in central Norway will be the location of Awakn's 4th clinic LIVE QUOTE
View Post
1234...11Page 3 of 11

KetaDash

Ketamine at Home Treatments
RESEARCH

Most Popular

Mystery Solved. Threshold Bioscience’s Neuroblo-Ibogaine!

Featured Editor | Curator -
500mg Iboga Total Alkaloid (TA) Extract. Someone posted this photo on LinkedIn, which we took as a tease....

$400 Million Man Tries Psychedelic Toads.

TESTIMONIALS Editor | Curator -
"This was the most profound experience of my life. I am stunned beyond comprehension. This molecule is without peer."

Compass Pathways (CMPS) Gets a Beat Down. Adding to 2025 Watch List, $2.36

Featured Editor | Curator -
The Montgomery-Asberg Depression Rating Scale. We were flying from Hawaii to Las Vegas yesterday and when we landed,...

LARGE CAP PSYCHEDELIC STOCKS

PSYCHEDELIC FUNDS AND ETFS

Copyright Revelers,io Media for Instiutional Analyst Inc.